A. S. Demir, S. Basceken / Tetrahedron: Asymmetry 24 (2013) 515–525
523
4.3.1. 1-Phenyl-3-(pyridin-2-yl)thiourea I
122.9, 118.8, 117.3, 114.2 (d, Ar-C); IR (ITR) mmax (cmꢀ1): 3202,
3035, 3004, 2917, 2851, 1590, 1575, 1527, 1382, 1275, 1133; m/z
(ESI-TOF) 729 (60, MH+), 757 (30), 759 (18), 500 (100), 360
(60%); HRMS (ESI-TOF): MH+, found 729.0762. C28H16F12N6S2 re-
quires 729.0764.
1H NMR (CDCl3): d 13.7 (s, 1H), 9.6 (s, 1H), 8.1 (s, 1H), 7.6 (m,
3H), 7.3 (m, 2H), 7.1 (m, 1H), 6.9 (m, 2H); 13C NMR (CDCl3): d
178.8 (s, C@S), 153.4 (s, pyridine-C-2), 145.6, 139.0 (d, Ar-C),
138.7 (s, ArC-NHR), 128.8, 126.3, 125.1, 118.3, 112.7 (d, Ar-C).
4.6. (2R,10S)-2-[Hydroxy-(4-nitrophenyl)methyl]cyclohex-an-1-
4.3.2. 1-(3,5-Bis(trifluoromethyl)phenyl)-3-(pyridin-2-yl)-thiou-
rea II
one 10a:12
1H NMR (CDCl3): d 14.2 (s, 1H), 9.0 (s, 1H), 8.2 (m, 3H), 7.7 (m,
2H), 7.1 (m, 1H), 6.8 (d, J = 8.3 Hz, 1H); 13C NMR (CDCl3): d 179.2 (s,
C@S), 152.8 (s, pyridine-C-2), 145.8 (d, Ar-C), 140.2 (s, ArC-NHR),
139.5 (d, Ar-C), 132.1, 131.8 (s, ArC-CF3), 124.5 (d, Ar-C), 124.4 (s,
C-F), 118.9, 112.5 (d, Ar-C).
Following the general procedure, compound 10a was obtained
as a slightly yellow solid, 90%, in a maximum of 99% ee. Rf = 0.4
(EtOAc/hexanes 1:2 v/v); The enantiomeric purity was determined
by HPLC on AD-H, hexanes/i-PrOH = 90:10, flow rate = 0.5 mL/min,
UV = 254 nm, anti/syn = 90/10, syn-10a tR = 36.2 min (major) and
tR = 42.5 min (minor), anti-10a tR = 62.1 min (major). 1H NMR
(CDCl3): d 8.21 (2H, d, J = 8.7 Hz), 7.51 (2H, d, J = 8.7 Hz), 4.90
(1H, d, J = 8.3 Hz), 4.09 (1H, s), 2.63–2.58 (1H, m), 2.53–2.47 (1H,
m), 2.41–2.33 (1H, m), 2.15–2.08 (1H, m), 1.85-1.36 (6H, m). 13C
NMR (CDCl3): d 214.7 (s, C@O), 148.4, 147.6, 127.9, 123.6, 74.0,
57.2, 42.7, 30.8, 27.6, 24.7.
4.4. 1,10-([2,20-Bipyridine]-4,40-diylbis(methylene))bis(3-(3,5-
bis(trifluoromethyl)phenyl)thiourea) 5
4,40-Dicarboxy-2,20-bipyridine (not shown), 4,40-dimethoxy-
carboyl-2,20-bipyridine (not shown), 4,40-bis(hydroxymethyl)-
2,20-bipyridine 2, 4,40-bis(bromomethyl)-2,20-bipyridine 3, and
4,40-bis(aminomethyl)-2,20-bipyridine 4 were prepared according
to literature methods.7
4.7. (2R,10S)-2-[Hydroxy-(3-nitrophenyl)methyl]cyclohex-an-1-
one 10b12
To a solution of 4,40-bis(aminomethyl)-2,20-bipyridine 4 (50 mg,
0.23 mmol) in dried chloroform (2 mL) was added dropwise 3,5-
Following the general procedure, compound 10b was obtained
as a slightly yellow solid, 70%, in a maximum of 91% ee. Rf = 0.4
(EtOAc/hexanes 1:2 v/v); The enantiomeric purity was determined
by HPLC on AD-H, hexanes/i-PrOH = 95/5, flow rate = 1.0 mL/min,
UV = 254 nm, anti/syn = 87/13, syn-10b tR = 26.5 min (major) and
tR = 29.7 min (minor), anti-10b tR = 33.5 min (major) and
tR = 43.3 min. 1H NMR (CDCl3): d 8.21 (1H, s), 8.15 (1H, d,
J = 8.2 Hz), 7.67 (1H, d, J = 7.6 Hz), 7.53 (1H, t, J = 7.8 Hz), 4.90
(1H, d, J = 8.4 Hz), 4.17 (1H, s), 2.67–2.61 (1H, m), 2.52–2.48 (1H,
m), 2.42–2.34 (1H, m), 2.13–2.10 (1H, m), 1.83 (1H, d,
J = 12.8 Hz), 1.73–1.53 (3H, m), 1.44–1.34 (1H, m). 13C NMR
(CDCl3): d 214.8 (s, C@O), 148.2, 143.3, 133.2, 129.2, 122.8, 122,
74, 57.1, 42.6, 30.7, 27.6, 24.6.
bis(trifluoromethyl)phenyl isothiocyanate (150 lL, 0.86 mmol).
The reaction mixture was stirred at room temperature and sud-
denly a precipitate formed. The suspension was then stirred for
6 h and added on dried hexane (15 mL). The resulting precipitate
was filtered off, washed with dry hexane, and dried to give the
compound
1,10-([2,20-bipyridine]-4,40-diylbis(methylene))bis(3-
(3,5-bis(trifluoromethyl)phenyl-)thiourea) 5 (149 mg, 85%) as a
slightly yellow solid; [Found: C, 47.43; H, 2.62; N, 11.0; S, 8.46.
C30H20F12N6S2 requires C, 47.62; H, 2.66; N, 11.11; S, 8.48%]; mp
225–228 °C; 1H NMR (CD3COCD3): d 9.8 (br s, 2H), 8.6 (app d,
J = 5.0 Hz, 2H), 8.5 (app s, 2H), 8.4 (app d, J = 4.8 Hz, 4H), 7.7 (app
s, 2H), 7.4 (app dd, J = 1.5, 5.0 Hz, 2H) , 5.07 (app d, J = 4.8 Hz,
4H); 13C NMR (CD3COCD3): d 183.2 (s, C@S), 156.9 (s, bipyridine-
C-2, bipyridine-C-20), 150.1 (d, bipyridine-C-6, bipyridine-C-60),
149.7 (s, bipyridine-C-4, bipyridine-C-40), 142.8 (s, ArC-NHR),
132.2, 131.9 (s, ArC-CF3), 128.4 (d, Ar-C), 125.7 (s, C-F), 123.8,
123.5, 123.0, 120.2, 117.8 (d, Ar-C), 47.6 (t, Ar-CH2R); IR (ITR) mmax
(cmꢀ1): 3238, 3105, 3034, 2917, 2851, 1598, 1573, 1527, 1382,
1273, 1174, 1132; m/z (ESI-TOF) 757 (100, MH+), 758 (40), 759
(18), 487 (30%); HRMS (ESI-TOF): MH+, found 757.1052.
4.8. (2R,10S)-2-[Hydroxy-(4-bromophenyl)methyl]cyclo-hexan-
1-one 10c12
Following the general procedure, compound 10c was obtained
as a yellow solid, 67%, in a maximum of 98% ee. Rf = 0.4 (EtOAc/
hexanes 1:2 v/v); The enantiomeric purity was determined by
HPLC on AD-H, hexanes/i-PrOH = 95/5, flow rate = 1.0 mL/min,
C30H20F12N6S2 requires 757.1078.
UV = 220 nm,
anti/syn = 91/9,
syn-10c
tR = 17.8 min
and
tR = 21.1 min, anti-10c tR = 27.9 min (minor) and tR = 32.5 min (ma-
jor). 1H NMR (CDCl3): d 7.47 (2H, d, J = 8.4 Hz), 7.19 (2H, d,
J = 8.3 Hz), 4.75 (1H, dd, J = 8.7, 2.6 Hz), 4.01 (1H, d, J = 2.7 Hz),
2.58-2.31 (3H, m), 2.11–2.06 (1H, m), 1.81–1.51 (3H, m), 1.34–
1.23 (1H, m). 13C NMR (CDCl3): d 215.2 (s, C@O), 140.1, 131.5,
128.6, 121.7, 74.2, 57.3, 42.7, 30.8, 27.7, 24.7.
4.5. 1,10-([2,20-Bipyridine]-4,40-diyl)bis(3-(3,5-bis(trifluoro-
methyl)phenyl)thiourea) 7
To a suspension of the commercially available 4,40-diamino-
2,20-bipyridine 6 (250 mg, 1.34 mmol) in acetone (50 mL) was
added dropwise 3,5-bis(trifluoromethyl)phenyl isothiocyanate
4.9. (2R,10S)-2-[Hydroxy-(4-(trifluoromethyl)phenyl)methyl]-
(500 lL, 2.7 mmol). The reaction mixture was stirred at room tem-
cyclohexan-1-one 10d12
perature for 48 h, until a clear solution was formed. After evapora-
tion of the excess acetone, the resulting product was purified by
chromatography on silica gel. The crude product 1,10-([2,20-bipyri-
dine]-4,40-diyl)bis(3-(3,5-bis-(trifluoromethyl)phenyl)thio-urea) 7
was obtained as a slightly green solid (689 mg, 70%); [Found: C,
46.10; H, 2.19; N, 11.51; S, 8.77. C28H16F12N6S2 requires C, 46.16;
H, 2.21; N, 11.53; S, 8.80%]; mp 124–126 °C; 1H NMR (CD3COCD3):
d 10.1 (br s, 2H), 8.6 (app d, J = 2.0 Hz, 2H), 8.5 (app d, J = 5.5 Hz,
2H), 8.3 (app s, 4H), 7.9 (app dd, J = 2.0, 5.5 Hz, 2H), 7.8 (app s,
2H); 13C NMR (CD3COCD3): d 181.1 (s, C@S), 150.7 (s, bipyridine-
C-4, bipyridine-C-40), 142.2 (s, ArC-NHR), 132.7 (d, bipyridine-C-6,
bipyridine-C-60), 132.3, 131.9 (s, ArC-CF3), 125.7 (s, C-F), 124.9,
Following the general procedure, compound 10d was obtained
as a slightly yellow solid, 75%, in a maximum of 98% ee. Rf = 0.4
(EtOAc/hexanes 1:2 v/v); The enantiomeric purity was determined
by HPLC on OD-H, hexanes/i-PrOH = 95/5, flow rate = 1.0 mL/min,
UV = 220 nm, anti/syn = 91/9, syn-10d tR = 8.7 min and tR = 9.5 min,
anti-10d tR = 11.2 min (major) and tR = 14.7 min (minor). 1H NMR
(CDCl3): d 7.60 (2H, d, J = 8.1 Hz), 7.44 (2H, d, J = 8.1 Hz), 4.85
(1H, dd, J = 8.6, 2.8 Hz), 4.09 (1H, d, J = 3.0 Hz), 2.63–2.57 (1H, m),
2.50–2.47 (1H, m), 2.40–2.32 (1H, m), 2.12–2.07 (1H, m), 1.82–
1.79 (1H, m), 1.71–1.49 (2H, m), 1.38–1.29 (1H, m). 13C NMR